EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)

Yi Zheng, Huaqing Liu, Xiuxia Wang, Haibo Li, Michaela Ruhmann, Anke Mayer, Oliver Dangel, Richard Ammer

CNS Drugs · 2025

DOI: 10.1007/s40263-024-01136-6 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift CNS Drugs, 2025. Verfasst von Yi Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anding Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Methylphenidate, Central Nervous System Stimulants. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MEDICE Arzneimittel Pütter GmbH & Co. KG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityMethylphenidateCentral Nervous System StimulantsHumansDouble-Blind MethodChildMaleFemaleAdolescentDelayed-Action PreparationsChinaTreatment OutcomeEast Asian People

Substanzen

MethylphenidateCentral Nervous System StimulantsDelayed-Action Preparations

Autor:innen und Institutionen

  • Beijing Anding Hospital of Capital Medical University, Beijing, China.
  • Beijing Huilongguan Hospital, Beijing, China.
  • The second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • The first Hospital of Jilin University, Changchun, Jilin, China.
  • MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany.
  • MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany. r.ammer@medice.de.

Förderung

  • MEDICE Arzneimittel Pütter GmbH & Co. KG

Zitieren

APA

Zheng, Y., Liu, H., Wang, X., Li, H., Ruhmann, M., Mayer, A., Dangel, O., & Ammer, R. (2025). Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). CNS Drugs. https://doi.org/10.1007/s40263-024-01136-6

Vancouver

Zheng Y, Liu H, Wang X, Li H, Ruhmann M, Mayer A, et al. Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). CNS Drugs. 2025. doi:10.1007/s40263-024-01136-6

BibTeX
@article{Zheng2025,
  author = {Zheng, Yi and Liu, Huaqing and Wang, Xiuxia and Li, Haibo and Ruhmann, Michaela and Mayer, Anke and Dangel, Oliver and Ammer, Richard},
  title = {Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)},
  journal = {CNS Drugs},
  year = {2025},
  doi = {10.1007/s40263-024-01136-6}
}
Kostenlos starten →